Feature|Articles|August 16, 2024
- Pharmaceutical Executive: July/August 2024
- Volume 44
- Issue 7/8
Pharmaceutical Executive: July/August 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive July/August 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 1 year ago
An AI Pulse Checkabout 1 year ago
Divergent Paths: Pharm Exec Profiles Five Recent Drug Launchesabout 1 year ago
A Promising Option: Exxuaabout 1 year ago
Opening the Door: Omvohabout 1 year ago
'Marked’ for Stardom?: Truqapabout 1 year ago
Branching Off: Wegovyabout 1 year ago
A Formidable First: Winrevairabout 1 year ago
The Future of Launch Excellence is Generative AIabout 1 year ago
From Potential to Value: Carving a Slice of the CGT ‘PIE'about 1 year ago
Big Bets, Bold StepsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
